These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Fortrea (NASDAQ:FTRE – Get Free Report) had its price objective lowered by investment analysts at Barclays from $25.00 to $12 ...

Fortrea (NASDAQ:FTRE – Get Free Report) had its target price decreased by analysts at The Goldman Sachs Group from $22.00 to ...

Project Optimus seeks to transform how doses are selected and optimised in oncology drug development. As this initiative ...

Bearish flow noted in Wolfspeed (WOLF) with 46,483 puts trading, or 6x expected. Most active are Mar-25 4 puts and Apr-25 6 calls, with total ...